2011 ASH Program Book - American Society of Hypertension

More documents

Recommendations

Info

Poster Category Presentation Posters will be displayed in the Second Floor Promenade. Saturday, May 21, 2011 Posters on Display: 4:30 PM – 7:30 PM • Poster Viewing: 6:00 PM – 7:00 PM Adolescent Hypertension and Obesity.............................. (PO-1 – PO-5) Antiatherosclerotic Drugs................................................... (PO-6 – PO-7) Cardiac Structure and Function/Imaging....................... (PO-8 – PO-10) Comprehensive Multi-Level Interventions for Hypertension Management in High-Risk Groups......(PO-11 – PO-30) Endothelial Function.......................................................(PO-31 – PO-45) Epidemiology/Special Populations................................(PO-46 – PO-78) Immune Mechanisms in Hypertension........................(PO-79 – PO-82) Metabolic Syndrome (Diabetes/Glycemic Control; Dysglycemic Drugs; Insulin Resistance).....................(PO-83 – PO-102) New Insights into the Role of Uric Acid in Hypertension............................................................(PO-103 – PO-104) Pediatric Hypertension...............................................(PO-105 – PO-111) Risk Factors (Lipids)....................................................(PO-112 – PO-115) Stroke.............................................................................(PO-117 – PO-119) Vascular Injury/Inflammation and Remodeling......(PO-120 – PO-123) Sunday, May 22, 2011 Posters on Display: 10:00 AM – 6:30 PM • Poster Viewing: 5:30 PM – 6:30 PM Featured Posters Blood Pressure Measurement/Monitoring......................(FP-1 – FP-4) Adolescent Hypertension..................................................(FP-5 – FP-8) Aldosterone and Anti-Aldosterone Agents..............(PO-124 – PO-130) Antihypertensive Drugs and Pharmacology............(PO-131 – PO-157) Clinical Trials................................................................(PO-158 – PO-184) Coronary Artery Disease............................................(PO-185 – PO-191) Genetics/Gene Therapy/Proteomics..........................(PO-192 – PO-198) Heart Failure/Hypertrophy (Diastolic Dysfunction)...............................................(PO-199 – PO-216) Hypertension in Patients with Chronic Kidney Disease.............................................................(PO-217 – PO-226) Kidney and Hypertension...........................................(PO-227 – PO-242) Off-Target Cardiovascular Effects of Non-Cardiovascular Drugs........................................(PO-243 – PO-244) Dagger (†) denotes that the presenting author has related disclosure information. 30
Poster Category Presentation Monday, May 23, 2011 Posters on Display: 10:00 AM – 5:30 PM • Poster Viewing: 4:30 PM – 5:30 PM Featured Posters Cardiac Structure and Function.................................... (FP-9 – FP-13) Arterial Structure and Compliance...........................(PO-245 – PO-259) Blood Pressure Measurement/Monitoring............(PO-260 – PO-305A) Cellular Mechanisms (Cell Biology; Cell Membrane Transport/Ion Channels; Coagulation/Thrombosis; Growth Factors).............(PO-306 – PO-308) Lipid Metabolism...........................................................................(PO-309) Neural Hormonal Mechanisms (Renin; Neural Control; Vasoactive Autacoids).....................................................................(PO-310 – PO-312) Non – Pharmacological Therapy (Alternative Medicine; Diet; Physical Activity).............................(PO-313 – PO-322) Nutrition and Cardiovascular Prevention................(PO-323 – PO-330) Obesity...........................................................................(PO-331 – PO-339) Patient – Provider-Healthcare System Issues...........(PO-340 – PO-355) Preclinical Models/Experimental Hypertension.....(PO-357 – PO-358) Pregnancy......................................................................(PO-359 – PO-361) Salt-Sensitive Mechanisms of Hypertension............(PO-362 – PO-364) Secondary Hypertension.............................................(PO-365 – PO-367) Late-Breaking Posters.........................................(LB-PO-01 – LB-PO-03) Dagger (†) denotes that the presenting author has related disclosure information. 31
Page 1 and 2: American Society of Hypertension, I
Page 3: Visit booth #1100 to find out more
Page 6 and 7: Past Presidents of the American Soc
Page 8 and 9: Program Color Key The pages of this
Page 10 and 11: Letter continued Following the Awar
Page 12 and 13: General Information continued Discl
Page 14 and 15: General Information continued ASH S
Page 16 and 17: General Information continued ASH P
Page 18 and 19: 2011 ASH Corporate Members Boehring
Page 20 and 21: ASH Leadership 2010-2011 Board of D
Page 22 and 23: Special Lecture Monday, May 23, 201
Page 24 and 25: Young Scholar Award* Monday, May 23
Page 26 and 27: Special Lecture Monday, May 23, 201
Page 28 and 29: 2011 Abstract Reviewers Lawrence J.
Page 30 and 31: More than half of hypertensive pati
Page 34 and 35: 2011 ASH Faculty Rajiv Agarwal, MD
Page 36 and 37: 2011 ASH Faculty continued David L.
Page 38 and 39: American Society of Hypertension, I
Page 40 and 41: Program Color Key The pages of this
Page 42 and 43: MAY 21 Saturday Morning Hypertensio
Page 44 and 45: MAY 21 Sessions Saturday Afternoon
Page 50 and 51: MAY 21 Posters Saturday Evening Pos
Page 52 and 53: MAY 22 Sunday morning Sessions cont
Page 54 and 55: MAY 22 Sessions Sunday Morning 9:00
Page 56 and 57: MAY 22 Sessions Sunday Morning 9:00
Page 58 and 59: MAY 22 Debates Sunday Morning 11:00
Page 60 and 61: MAY 22 Plenary Session I Sunday Aft
Page 62 and 63: MAY 22 Special Sessions Sunday Afte
Page 64 and 65: MAY 22 Sessions Sunday Afternoon 3:
Page 66 and 67: MAY 23 Satellite Symposium 6:00 AM
Page 68 and 69: MAY 23 Sessions Monday morning 8:00
Page 78 and 79: MAY 23 Plenary Session II Monday Af
Page 80 and 81: MAY 24 Sessions Tuesday Morning 8:1
Page 82 and 83:
MAY 24 Sessions Tuesday Morning 10:
Page 84 and 85:
MAY 24 Sessions Tuesday Morning 10:
Page 87 and 88:
2011 American Society of Hypertensi
Page 89 and 90:
Saturday Afternoon MAY 21 Posters 4
Page 91 and 92:
Saturday Afternoon MAY 21 Posters P
Page 93 and 94:
Saturday Afternoon MAY 21 Posters E
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Saturday Afternoon MAY 21 Posters I
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Sunday Morning MAY 22 Posters 10:00
Page 109 and 110:
Sunday Morning MAY 22 Posters 10:00
Page 111 and 112:
Sunday Morning MAY 22 Posters PO-13
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Monday Morning Afternoon MAY 21 23
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Faculty Disclosure Listing Rajiv Ag
Page 149 and 150:
Faculty Disclosure Listing continue
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
ASH Hypertension Resource Pavilion
Page 159 and 160:
2011 ASH Innovations Theater Rhinel
Page 161 and 162:
2011 ASH Exhibitors continued A & D
Page 163 and 164:
2011 ASH Exhibitors continued David
Page 165 and 166:
2011 ASH Exhibitors continued Inter
Page 167 and 168:
2011 ASH Exhibitors continued Novar
Page 169 and 170:
2011 ASH Exhibitors continued Wiley
Page 171 and 172:
Author Index Berezina, Aelita V., 8
Page 173 and 174:
Author Index Eguchi, Kazuo, 110, 13
Page 175 and 176:
Author Index Ikeda, Yasuhiro, 116 I
Page 177 and 178:
Author Index Makani, Harikrishna, 1
Page 179 and 180:
Author Index Rabelink, Ton J., 93 R
Page 181 and 182:
Author Index Tatsis, I., 92, 124 Ta
Page 183 and 184:
Hilton New York Floor Plans Second
Page 185 and 186:
Hilton New York Floor Plans Fourth
Page 187 and 188:
Tekamlo (aliskiren and amlodipine)
Page 189 and 190:
25% (systolic) and 27% (diastolic)
Page 191 and 192:
Two cases of angioedema with respir
Page 193 and 194:
amlodipine and sildenafil were used
Page 195 and 196:
Amlodipine besylate Single oral dos
show all

2011 ASH Program Book - American Society of Hypertension

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?